Russian COVID vax found 91.6pc efficient in Phase III trial: RDIF
The Gamaleya National Research Centre and the Russian Direct Investment Fund (RDIF) on Tuesday said that interim results of a…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.